Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and Amlodipine Extension Study in Hypertension
NCT00409851Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2003
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of valsartan and amlodipine in hypertension (HTN), sponsored by Novartis. Primary endpoint: Change from baseline in mean sitting diastolic blood pressure at trough at 52 weeks. Started Apr 2003; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00409851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409851.